Skip to main navigation

Skip to Content

Overview
News & Events
- News Releases
- Events & Presentations
Governance
Stock Information
Financials
- SEC Filings
Resources

News Releases

Year

Jun 27, 2022

Tango Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes

Jun 08, 2022

Tango Therapeutics to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference

May 11, 2022

Tango Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights

May 09, 2022

Tango Therapeutics to Participate in the Guggenheim Synthetic Lethality Day 2022

Mar 28, 2022

Tango Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights

Mar 08, 2022

Tango Therapeutics Announces Presentation of Preclinical Data on TNG908, USP1 Inhibitor Program and Discovery Platform in Three Abstracts Accepted at AACR 2022 Annual Meeting

Mar 03, 2022

Tango Therapeutics Announces Presentation of TNG908 Preclinical Combination Data at 2022 ESMO Targeted Anticancer Therapies Congress

Feb 28, 2022

Tango Therapeutics to Participate in Upcoming Investor Conferences

Feb 02, 2022

Tango Therapeutics to Participate in Upcoming Investor Conferences

Jan 24, 2022

Tango Therapeutics Announces Clearance of TNG908 IND by FDA and Recent Pipeline Progress Updates

Print

RSS Feeds

Email Alerts

Contact IR

Tango Therapeutics, Inc
100 Binney Street, Suite 700
Cambridge, MA 02142
Tel: +1-857-320-4900

contact | careers |